Evidence map›Paper›PMID 37047524›Full record

ArticleInternational journal of molecular sciences2023

Immunomodulatory Aspects of Therapeutic Plasma Exchange in Neurological Disorders-A Pilot Study.

Fabian Foettinger, Georg Pilz, Peter Wipfler, Andrea Harrer, Jan Marco Kern, Eugen Trinka, Tobias Moser

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Fabian FoettingerDepartment of Neurology, Christian Doppler University Hospital, European Reference Network EpiCARE, Paracelsus Medical University, 5020 Salzburg, Austria.
Georg PilzDepartment of Neurology, Christian Doppler University Hospital, European Reference Network EpiCARE, Paracelsus Medical University, 5020 Salzburg, Austria.
Peter WipflerDepartment of Neurology, Christian Doppler University Hospital, European Reference Network EpiCARE, Paracelsus Medical University, 5020 Salzburg, Austria.ORCID 0000-0003-4982-4855
Andrea HarrerDepartment of Neurology, Christian Doppler University Hospital, European Reference Network EpiCARE, Paracelsus Medical University, 5020 Salzburg, Austria.ORCID 0000-0001-7717-6125
Jan Marco KernDepartment of Clinical Microbiology and Hygiene, Paracelsus Medical University, 5020 Salzburg, Austria.
Eugen TrinkaDepartment of Neurology, Christian Doppler University Hospital, European Reference Network EpiCARE, Paracelsus Medical University, 5020 Salzburg, Austria.
Tobias MoserDepartment of Neurology, Christian Doppler University Hospital, European Reference Network EpiCARE, Paracelsus Medical University, 5020 Salzburg, Austria.ORCID 0000-0002-5397-5595
Paracelsus Medical University · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Therapeutic plasma exchange (TPE) is used for drug-resistant neuroimmunological disorders, but its mechanism of action remains poorly understood. We therefore prospectively explored changes in soluble, humoral, and cellular immune components associated with TPE. We included ten patients with neurological autoimmune disorders that underwent TPE and assessed a panel of clinically relevant pathogen-specific antibodies, total serum immunoglobulin (Ig) levels, interleukin-6 (IL-6, pg/mL), C-reactive protein (CRP, mg/dL), procalcitonin (PCT, µg/L) and major lymphocyte subpopulations (cells/µL). Blood was collected prior to TPE (pre-TPE, baseline), immediately after TPE (post-TPE), as well as five weeks (follow-up1) and 130 days (follow-up2) following TPE. Pathogen-specific antibody levels were reduced by -86% (

Indexed as

Nervous System DiseasesPlasma ExchangeHumansInterleukin-6Pilot ProjectsPlasmapheresisRetrospective StudiesInterleukin-6antibody titerscytokinesinterleukinmode of actionmultiple sclerosisplasma separation

Identifiers

PMID37047524
PMCPMC10095570
OpenAlexW4362473709

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.